Adenovirus type 5 E4 Orf3 protein targets promyelocytic leukaemia (PML) protein nuclear domains for disruption via a sequence in PML isoform II that is predicted as a protein interaction site by bioinformatic analysis

Journal of General Virology

Volumn 90, Issue 1, 2009, Pages 95-104

  Leppard, Keith N ^a   Emmott, Edward ^a,b   Cortese, Marc S ^c   Rich, Tina ^c  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ISOPROTEIN; PROMYELOCYTIC LEUKEMIA PROTEIN; PROMYELOCYTIC LEUKEMIA PROTEIN II; PROTEIN ORF3; UNCLASSIFIED DRUG; VIRUS PROTEIN; NUCLEAR PROTEIN; PML PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN;

ADENOVIRUS 5; AMINO ACID SEQUENCE; ARTICLE; BINDING SITE; BIOINFORMATICS; CARBOXY TERMINAL SEQUENCE; CELL NUCLEUS; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PREDICTION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; ADENOVIRUS; BIOLOGY; GENETICS; METABOLISM; METHODOLOGY; MOLECULAR GENETICS; PHYSIOLOGY; PROTEIN ANALYSIS; SEQUENCE ALIGNMENT;

HUMAN ADENOVIRUS TYPE 5;

ADENOVIRIDAE; ADENOVIRUS E4 PROTEINS; AMINO ACID SEQUENCE; COMPUTATIONAL BIOLOGY; CONSERVED SEQUENCE; HUMANS; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN INTERACTION MAPPING; PROTEIN ISOFORMS; SEQUENCE ALIGNMENT; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 59849108860     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.005512-0     Document Type: Article

References (46)

1. Araujo, F. D., Strecker, T. H., Carson, C. T., Lee, D. V. & Weitzman, M. D. (2005). Adenovirus type 5 E4orf3 protein targets the Mre11 complex to cytoplasmic aggresomes. J Virol 79, 11382-11391.
2. Beech, S. J., Lethbridge, K. J, Killick, N., McGlincy, N. & Leppard, K. N. (2005). Isoforms of the promyelocytic leukemia protein differ in their effects on ND10 organization. Exp Cell Res 307, 109-117.
3. Bernardi, R. & Pandolfi, P. P. (2007). Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies. Nat Rev Mol Cell Biol 8, 1006-1016.
4. Bernardi, R., Scaglioni, P. P., Bergmann, S., Horn, H. F., Vousden, K. H. & Pandolfi, P. P. (2004). PML regulates p53 stability by sequestering Mdm2 to the nucleolus. Nat Cell Biol 6, 665-672.
5. Borden, K. L. B., Lally, J. M., Martin, S. R., O'Reilly, N. J., Solomon, E. & Freemont, P. S. (1996). In vivo and in vitro characterization of the B1 and B2 zinc- binding domains firom the acute promyelocytic leukemia protooncoprotein PML. Proc Natl Acad Sci U S A 93, 1601-1606.
6. Bourhis, J. M., Johansson, K., Receveur-Brechot, V., Oldfield, C. J., Dunker, A. K., Canard, B. & Longhi, S. (2004). The C-terminal domain of measles virus nucleoprotein belongs to the class of intrinsically disordered proteins that fold upon binding to their physiological partner. Virus Res 99, 157-167.
7. Callaghan, A. J., Aurikko, J. P., Ilag, L. L., Grossman, J. G., Chandran, V., Kuhnel, K., Poljak, L., Carpousis, A. J., Robinson, C. V. & other authors (2004). Studies of the RNA degradosome-organizing domain of the Escherichia coli ribonuclease RNase E. J Mol Biol 340, 965-979.
8. Carvalho, T., Sealer, J. S., Ohman, K., Jordan, P., Pettersson, U., Akusjarvi, G., Carmofonseca, M. & Dejean, A. (1995). Targeting of adenovirus E1A and E4-ORF3 proteins to nuclear matrix-associated PML bodies. J Cell Biol 131, 45-56.
9. Condemine, W., Takahashi, Y., Zhu, J., Puvion-Dutilleul, F., Guegan, S., Janin, A. & de The, H. (2006). Characterization of endogenous human promyelocytic leukemia isoforms. Cancer Res 66, 6192-6198.
10. Condemine, W., Takahashi, Y., Le Bras, M. & de The, H. (2007). A nucleolar targeting signal in PML-I addresses PML to nucleolar caps in stressed or senescent cells. J Cell Sci 120, 3219-3227.
11. Doucas, V., Ishov, A. M., Romo, A., Jugullon, H., Weitzman, M. D., Evans, R. M. & Maul, G. G. (1996). Adenovirus replication is coupled with the dynamic properties of the PML nuclear structure. Genes Dev 10, 196-207.
12. Evans, J. D. & Hearing, P. (2003). Distinct roles of the adenovirus E4 ORF3 protein in viral DNA replication and inhibition of genome concatenation. J Virol 77, 5295-5304.
13. Everett, R. D. & Chelbi-Alix, M. K. (2007). PML and PML nuclear bodies: implications in antiviral defence. Biochimie 89, 819-830.
14. Everett, R. D. & Maul, G. G. (1994). HSV-1 IE protein Vmw110 causes redistribution of PML. EMBO J 13, 5062-5069.
15. Everett, R. D. & Murray, J. (2005). ND10 components relocate to sites associated with herpes simplex virus type 1 nucleoprotein complexes during virus infection. J Virol 79, 5078-5089.
16. Everett, R. D., Rechter, S., Papior, P., Tavalai, N., Stamminger, T. & Orr, A. (2006). PML contributes to a cellular mechanism of repression of herpes simplex virus type 1 infection that is inactivated by ICPO. J Virol 80, 7995-8005.
17. Everett. R. D., Parada, C., Gripon, P., Sirma, H. & Orr, A. (2008). Replication of ICP0-null mutant herpes simplex virus type 1 is restricted by both PML and Sp100. J Virol 82, 2661-2672.
18. Fagioli, M., Alcalay, M., Pandolfi, P. P., Venturini, L., Mencarelli, A., Simeone, A., Acampora, D., Grignani, F. & Pelicci, P. G. (1992). Alternative splicing of PML transcripts predicts expression of several carboxyterminally different protein isoforms. Oncogene 7, 1083-1091.
19. Fagioli, M., Alcalay, M., Tomassoni, L., Ferrucci, P. F., Mencarelli, A., Riganelli, D., Grignani, F., Pozzan, T., Nicolletti, I. & other authors (1998). Cooperation between the RING+B1-B2 and coiled-coil domains of PML is necessary for its effects on cell survival. Oncogene 16, 2905-2913.
20. Hoppe, A., Beech, S. J., Dimmock, J. & Leppard, K. N. (2006). Interaction of the adenovirus type 5 E4 Orf3 protein with promyelocytic leukemia protein isoform II is required for ND10 disruption. J Virol 80, 3042-3049.
21. Ishov, A. M. & Maul, G. G. (1996). The periphery of nuclear domain 10 (ND10) as site of DNA virus deposition. J Cell Biol 134, 815-826.
22. Janderová-Rossmeislová, L., Nováková, Z., Vlasáková, J., Phillmonenko, V., Hozák, P. & Hodný, Z. (2007). PML protein association with specific nucleolar structures differs in normal, tumor and senescent human cells. J Struct Biol 159, 56-70.
23. Jenson, K., Shiels, C. & Freemont, P. S. (2001). PML protein isoforms and the RBCC/TRIM motif. Oncogene 20, 7223-7233.
24. Kalderon, D., Roberts, B. L., Richardson, W. D. & Smith, A. E. (1984). A short amino-acid sequence able to specify nuclear location. Cell 39, 499-509.
25. Kelly, C., van Driel, R. & Wilkinson, G. W. G. (1995). Disruption of PML-associated nuclear bodies during human cytomegalovirus infection. J Gen Virol 76, 2887-2893.
26. Leppard, K. N. & Dimmock J. (2006). Virus interactions with PML nuclear bodies. In Viruses and the Nucleus, pp. 213-245. Edited by J. Hiscox. Wiley.
27. Liu, Y., Shevchenko, A. & Berk, A. J. (2005). Adenovirus exploits the cellular aggresome response to accelerate inactivation of the MRN complex. J Virol 79, 14004-14016.
28. Longhi, S., Receveur-Brechot, V., Karlin, D., Johansson, K., Darbon, H., Bhella, D., Yeo, R., Finet, S. & Canard, B. (2003). The C-terminal domain of the measles virus nucleoprotein is intrinsically disordered and folds upon binding to the C-terminal moiety of the phosphoprotein. J Biol Chem 278, 18638-18648.
29. Mattsson, K., Pokrovskaja, K., Kiss, C., Klein, G. & Szekely, L. (2001). Proteins associated with the promyelocytic leukemia gene product (PML)-containing nuclear body move to the nucleolus upon inhibition of proteasome-dependent protein degradation. Proc Natl Acad Sci U S A 98, 1012-1017.
30. Mohan, A. C., Oldfield, C. J., Radlvojac, P., Vacic, V., Cortese, M. S., Dunker, A. K. & Uversky, V. N. (2006). Analysis of molecular recognition features (MoRFs). J Mol Biol 362, 1043-1059.
31. Nevels, M., Tauber, B., Kremmer, E., Spruss, T., Wolf, H. & Dobner, T. (1999). Transforming potential of the adenovirus type 5 E4orf3 protein. J Virol 73, 1591-1600.
32. Obradovic, Z., Peng, K., Vucetic, S., Radivojac, P. & Dunker, A. K. (2005). Exploiting heterogeneous sequence properties improves prediction of protein disorder. Proteins 61 (Suppl. 7), 176-182.
33. Oldfield, C. J., Chong, Y., Cortese, M. S., Romero, P., Uversky, V. N. & Dunker, A. K. (2005). Coupled folding and binding with alpha-helix-forming molecular recognition elements. Biochemistry 44, 12454-12470.
34. Oldfield, C. J., Meng, J., Yang, J. Y., Yang, M. O., Uversky, V. N. & Dunker, A. K. (2008). Flexible nets: disorder and induced fit in the associations of p53 and 14-3-3 with their partners. BMC Genomics 9 (Suppl. 1), S1.
35. Peng, H. Z., Feldman, I. & Rauscher, F. J., 3rd (2002). Hetero-oligomerization among the TIF family of RBCC/TRIM domain-containing nuclear cofactors: a potential mechanism for regulating the switch between coactivation and corepression. J Mol Biol 320, 629-644.
36. Romero, P., Obradovic, Z., Kissinger, C. R., Villafranca, J. E. & Dunker, A. K. (1997). Identifying disordered regions in proteins from amino acid sequences. In. IEEE International Conference on Neural Networks, pp. 90-95.
37. Romero, P., Obradovic, D., Li, X., Garner, E. C., Brown, C. J. & Dunker, A. K. (2001). Sequence complexity of disordered protein. Proteins 42, 38-48.
38. Salomoni, P. & Bellodi, C. (2007). New insights into the cytoplasmic function of PML. Histol Histopathol 22, 937-946.
39. Scaglioni, P. P., Yung, T. M., Cai, L. F., Erdjument-Bromage, H., Kaufman, A. J., Singh, B., Teruya-Feldstein, J., Tempst, P. & Pandolfi, P. P. (2006). A CK2-dependent mechanism for degradation of the PML tumor suppressor. Cell 126, 269-283.
40. Shen, T. H., Lin, H.-K., Scaglioni, P. P., Yung, T. M. & Pandolfi, P. P. (2006). The mechanisms of PML-nuclear body formation. Mol Cell 24, 331-339.
41. Sternsdorf, T., Jensen, K. & Will, H. (1997). Evidence for covalent modification of the nuclear dot-associated proteins PML and Sp100 by PIC1/SUMO-1. J Cell Biol 139, 1621-1634.
42. Strecker, T. H., Carson, C. T. & Weitzman, M. D. (2002). Adenovirus oncoproteins inactivate the Mre11-Rad50-NBS1 DNA repair complex. Nature 418, 348-352.
43. Stracker, T. H., Lee, D. V., Carson, C. T., Araujo, F. D., Ornelles, D. A. & Weitzman, M. D. (2005). Serotype-specific reorganization of the Mre11 complex by adenoviral E4orf3 proteins. J Virol 79, 6664-6673.
44. Ullman, A. J. & Hearing, P. (2008). The cellular proteins PML and Daxx mediate an innate antiviral defence antagonized by the adenovirus E4 ORF3 protein. J Virol 82, 7325-7335.
45. Ullman, A. J., Reich, N. C. & Hearing, P. (2007). Adenovirus E4 ORF3 protein inhibits the interferon-mediated antiviral response. J Virol 81, 4744-4752.
46. Yondola, M. A. & Hearing, P. (2007). The adenovirus E4 ORF3 protein binds,and reorganizes the TRIM family member transcriptional intermediary factor 1 alpha. J Virol 81, 4264-4271.